Personal tools

Research

Workshops & Conferences
For Faculty & Staff
- Reference Search
  - 2006 References
For PostDocs & Mentors
For Students
For Industry
About the Office of Research
Staff / Contact Information
Offices
Clinical Trials
CPM - Predictive Medicine
CTSI - CTSA
EVPRI Centers and Institutes
Human Subjects Protection Program
Research Integrity Program
Policies & Procedures
Research Handbook
Unit Research Offices
Bucks for Brains
Research Informatics Office Questionnaire
UofL Centers & Institutes

You are here: Home → For Faculty & Staff → Reference Search → 2006 References → Sampson and Callen, Aug 2006, The Cutting Edge: Thalidomide for Type 1 Cryoglobulinemic Vasculopathy

Sampson and Callen, Aug 2006, The Cutting Edge: Thalidomide for Type 1 Cryoglobulinemic Vasculopathy

Reference

Sampson, A. and Callen, J. P. The Cutting Edge: Thalidomide for Type 1 Cryoglobulinemic Vasculopathy. Archives of Dermatology, 142(8): 972-974. (2006).

Keywords

34
Cryoglobulinemic Vasculopathy
ME
ref-journal
thalidomide

Document Actions

Send this
Print this